Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab Combined With Eldecalcitol in High-Risk Patients With Osteoporotic Fractures in Type 2 Diabetes
NCT07063797Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Feb 2026
- Primary completion
- Jul 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of eldecalcitol in osteoporosis (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Change rate of lumbar bone density at 12 months. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
eldecalcitol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT07063797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07063797.